Concord Wealth Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10
Closed -$1.85K 883
2024
Q4
$1.85K Hold
10
﹤0.01% 717
2024
Q3
$2.11K Hold
10
﹤0.01% 741
2024
Q2
$1.34K Hold
10
﹤0.01% 702
2024
Q1
$2.15K Hold
10
﹤0.01% 749
2023
Q4
$2.03K Hold
10
﹤0.01% 712
2023
Q3
$1.98K Hold
10
﹤0.01% 871
2023
Q2
$3.25K Hold
10
﹤0.01% 796
2023
Q1
$2.34K Hold
10
﹤0.01% 788
2022
Q4
$2.52K Buy
+10
New +$2.13K ﹤0.01% 897
2022
Q3
Sell
-10
Closed -$2K 623
2022
Q2
$2K Hold
10
﹤0.01% 1029
2022
Q1
$3K Hold
10
﹤0.01% 1020
2021
Q4
$2K Hold
10
﹤0.01% 1132
2021
Q3
$2K Hold
10
﹤0.01% 752
2021
Q2
$2K Hold
10
﹤0.01% 889
2021
Q1
$2K Hold
10
﹤0.01% 826
2020
Q4
$2K Buy
+10
New +$1.64K ﹤0.01% 535

Other funds holding INSP

Concord Wealth Partners's INSP Position: Q1 2025 in Review

Concord Wealth Partners sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 10 shares — an estimated $1.85K sold.

Concord Wealth Partners first reported a position in INSP in Q4 2020 and held it in 16 quarters. The position peaked at $3.25K in Q2 2023. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • Concord Wealth Partners reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • Concord Wealth Partners sold 10 Inspire Medical Systems shares in Q1 2025, an estimated $1.85K.
  • Concord Wealth Partners first reported a position in Inspire Medical Systems in Q4 2020 and held it in 16 quarters.
  • Concord Wealth Partners's Inspire Medical Systems position peaked at $3.25K in Q2 2023.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on Concord Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.